Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a pharmaceutical company based in China specializing in the research, development, and production of biodiagnostic reagents and vaccines. With a Risk Rating Score of 29.9, the company is assessed as having a medium risk. Beijing Wantai Biological Pharmacy offers a wide range of products including ELISA series, Colloidal gold series, Bole series, Confirmation series, Automatic blood group analyzer and reagent, Chemiluminescence series, Nucleic acid series, and Research Series. Known for its commitment to ESG principles, Beijing Wantai Biological Pharmacy remains dedicated to sustainability and governance practices.